Indego

Description

The Indego® can be used for therapy as a gait training tool.  The Indego Personal can also be employed as a supplementary mobility aid to a wheelchair.  In addition to being able to see people eye-to-eye, research using this and other assistive medical exoskeletons has shown a strong correlation between standing up and a multitude of secondary benefits.  These positive effects include but are not limited to improved bowel control, increased bone density and reduction in pressure sores.

The Indego exoskeleton features a modular design and can be taken apart for easy storage and transportation.  It is also the first exoskeleton to feature an iOS pad that comes preloaded on an iPod Touch.  The app is designed to provide effortless tracking of user’s utilization of the wearable, export the data and change the device settings.  Both the Indego Therapy and Indego Personal have a CE Mark allowing it to be sold commercially in Europe and the U.S.  Also, the Indego has been approved by the FDA for clinical and personal use for patients with spinal cord injury.

In the U.S. the Indego is marketed for individuals with complete and incomplete spinal cord injury T4 or below.  For Europe, it is marketed for individuals with lower limb weakness or paralysis (note: due to various regulations in North America, Europe, and Asia, it is very common for exoskeleton devices to have different listed capabilities).

Indego design specifications:

• Hip-knee powered exoskeleton
• Li-ion batteries
• Total assembled device weight of 12kg (26lb)
• Modular
• Ability to export data using an iOS app
• Bluetooth connectivity
• Color LED and vibration user feedback (note: Recent independent research has shown haptic feedback to be instrumental in some gait rehabilitation cases)
• Built in functional electrical stimulation (FES) interface (select models)

User requirements:

• Height: 155 to 191 cm (5’1” to 6’3”)
• Maximum weight: 113 kg (250  lb)
• Maximum hip width: 42.2 cm (16.6”)
• Femur length: 35 to 47 cm (14”-18.5”)
• Spasticity score: Modified Ashworth Score 3 or lower
• Enough upper body strength to balance and advance with forearm crutches, a wheeled or platform walker.

Research articles:

• Utilization of Robotic Exoskeleton for Overground Walking in Acute and Chronic Stroke – Front. Neurorobot., 01 September 2021

Look for news on the Indego and Parker Hannifin on the Exoskeleton Report.

Indego – Parker Hannifin Corporation, Cleveland, Ohio, U.S., website

Exoskeleton Report does not endorse one exoskeleton product over another.  The exoskeleton catalog is purely for educational purposes.  The catalog is meant to provide an easily accessible birds-eye view of the exoskeleton industry, and a quick method to sort exoskeletons by type and purpose.  All prices are approximate and are meant to provide a general sense of the cost of the devices.